In a study exploring MRSA BSI predictors in HIV-infected patients, multivariate analysis revealed that frequent hospitalization, low numbers of CD4+ peripheral cells, and previous administration of beta-lactams were found to be independent risk factors of MRSA development [59], which is partly in line with the findings in cancer patients. The gene discussed is CD4; the disease is cancer.